In Great Britain, a dog probiotic containing Enterococcus faecium is sold as a complementary feed or a feed additive — not as a veterinary medicine. That single legal fact explains almost everything about how these products are labelled, what they are allowed to say, and why the wording on the back of the tub sounds so much more cautious than the marketing on the front. Only a product authorised by the Veterinary Medicines Directorate (VMD) may make a medicinal claim, and no canine probiotic on the British market holds that kind of licence.
This guide is for owners in Britain who want to know what the evidence for E. faecium actually shows, what a UK label may lawfully say, and how to raise it with their own RCVS-registered veterinary surgeon. For the strain-by-strain background, see our parent guide on Enterococcus faecium for dogs.
Complementary feed, feed additive, or veterinary medicine: the three boxes
British and retained EU feed law puts everything you can buy for your dog into one of a small number of categories, and the category dictates the claim. Getting this straight is the fastest way to read a probiotic label honestly.
| Category | Who oversees it | What it may claim | Typical example |
|---|---|---|---|
| Complementary feed (most dog probiotics) | Trading Standards / feed law; APHA for feed business registration | Nutritional and maintenance wording only — "may support normal digestion". No treatment claims. | A liquid or powder probiotic added to food |
| Authorised zootechnical feed additive | GB feed additive register (retained EU framework) | The narrow function the strain was authorised for, at the authorised dose range | E. faecium NCIMB 10415 in a complete diet |
| Veterinary medicinal product | VMD, under the Veterinary Medicines Regulations | Treatment, prevention or cure of a named condition | A licensed antibiotic or anti-parasitic |
E. faecium NCIMB 10415 is notable because it is one of the relatively few live micro-organisms authorised as a zootechnical feed additive within the EU/GB retained framework, including for use in dogs. That authorisation is a safety and efficacy assessment for a defined purpose in feed — it is emphatically not a medicines licence, and it does not entitle anyone to say the strain treats anything.
What the canine research genuinely shows — and where it stops
The honest summary is that the evidence for E. faecium in dogs is thinner and more mixed than the category's popularity suggests.
The largest controlled dataset comes from a double-blinded, placebo-controlled shelter study of 217 cats and 182 dogs. In cats, diarrhoea lasting two days or more occurred in 7.4% of the probiotic group versus 20.7% of placebo (P = .0297). In the dogs, no statistical difference was detected — diarrhoea was uncommon in both canine groups, so the trial had little room to show an effect (PMID 21689152).
A second trial gave every dog metronidazole and randomised them to E. faecium SF68 or placebo for seven days. The proportion with normal stools by day 7 was 68.8% with the combination versus 37.5% with metronidazole alone, but that difference was not statistically significant (P = .1556). The percentage of days with normal stools did reach significance: 65.6% versus 46.9% (P = .0496) — a modest, real, but narrow finding (PMID 29291770).
A randomised crossover study in 20 adult dogs with giardiasis was fully negative: no difference in cyst shedding, faecal antigen, faecal IgA, or leukocyte phagocytic activity (PMID 19298607).
A 2022 randomised, double-blinded crossover in 11 healthy dogs fed E. faecium NCIMB 10415 in a complete diet found owners reported 0.6 ± 0.3 fewer days of loose stools and cholesterol fell versus baseline (p = 0.008) — but the authors were candid that both diets raised faecal acetate, butyrate and microbial diversity, and that these "effects were observed regardless of the addition of E. faecium" (PMID 36611752). A blinded study in 36 healthy dogs given SF68 for 14 days found no significant change in liver enzymes; cholesterol decreased by day 28 (P < .01) while triglycerides increased (P < .05), and one dog developed hypertriglyceridaemia — worth knowing if your practice already monitors a dog with a pancreatitis history (PMID 31578761).
A 2025 transport-stress study of E. faecium Kimate-X reported significantly lower cortisol after transport and higher faecal short-chain fatty acids (PMID 40431505) — though all authors were employed by Diprobio (Shanghai), which belongs in any honest reading of it. Earlier work in puppies from weaning to one year, at 5 × 108 CFU/day SF68, reported higher faecal IgA and higher distemper-vaccine-specific antibody (PMID 12672936); that abstract describes neither randomisation nor placebo control and gives no p-values, and the work was Nestec-affiliated, so it is suggestive rather than decisive.
The antimicrobial stewardship angle British owners should understand
If there is one reason UK readers should care about E. faecium beyond stool quality, it is antimicrobial resistance. British small-animal practice has spent a decade tightening antibiotic use through initiatives such as the BSAVA's PROTECT ME framework, which pushes practices to reserve antibiotics for cases that genuinely need them — and acute, self-limiting canine diarrhoea is a classic scenario where an antibiotic often adds little. If supportive care gives an owner and their veterinary surgeon the confidence to skip metronidazole, that is a stewardship win even where the direct effect of a supplement is modest.
Enterococci are also part of the resistance story themselves. A survey of 469 enterococci from 610 dog and cat samples found 68.92% were multidrug resistant, and framed pets as a reservoir with public-health implications (PMID 36724969). A review of animal-origin Enterococcus describes both intrinsic and acquired mechanisms, including optrA and cfr genes (PMID 30051804).
This is not an argument against probiotic strains — an authorised feed-additive strain is assessed for transferable resistance genes before it can be used, which is precisely why strain identity to the deposit number matters more than the genus name on the front label.
What we will not claim
- We do not claim E. faecium resolves diarrhoea in dogs. The largest canine dataset showed no effect in dogs.
- We do not claim it helps with Giardia. The dedicated canine crossover trial was negative.
- We do not claim it improves vaccine response in dogs. That rests on a single 2003 non-randomised study.
- We do not claim any probiotic treats, cures or prevents IBD, pancreatitis, atopic dermatitis or any other diagnosis. Under UK rules, only a VMD-authorised medicine could make that kind of claim, and no probiotic holds one.
Reading a British probiotic label without being misled
Product testing has been a genuine weak point in this category. When 19 commercial pet diets claiming probiotic content were analysed, no product contained all the organisms listed, and five (26%) showed no relevant growth at all (PMID 12677689). That study is old, but it set the standard for why you should look for evidence a batch was actually tested.
Four things worth checking on a UK-sold tub or bottle:
- Strain to the deposit number — "NCIMB 10415" or "SF68", not just "Enterococcus faecium".
- The legal category — "complementary feed for dogs" is the honest and expected wording.
- Batch verification — a certificate of analysis is the practical answer to the Weese finding.
- A UK or EU contact address and feed business details, so there is someone accountable.
Formats differ in ways that are about your dog, not about which is "better". Chews are palatable, pre-portioned, easy for a dog walker to give correctly, and often the format a fussy dog will actually accept. Powders suit large dogs and multi-dog households on cost. Liquids let you titrate by body weight into food or water, which suits small breeds and dogs who reject anything solid in the bowl. Our breakdown of liquid vs powder vs chews goes through the trade-offs, and if you want single-strain comparisons, see FortiFlora for dogs and Saccharomyces boulardii for dogs.
Where a multi-strain liquid fits
The canine E. faecium literature is single-strain and narrow, and the dysbiosis seen in dogs with chronic gut signs involves broad shifts in the microbial community rather than one missing organism (PMID 27160005) — so some owners prefer a multi-strain approach alongside diet rather than betting on one species. The Pure Majesty Pets 3B Liquid Probiotic combines multiple live strains with prebiotic fibres and digestive enzymes in a liquid dosed in drops by body weight, so it mixes into food or water. It is manufactured in North America under GMP with a certificate of analysis on every batch, and ships free worldwide, including to the UK. Like every canine probiotic sold in Britain, it is a complementary feed — not a VMD-authorised medicine — and nothing here is a claim to treat disease. For the wider category, our pillar guide to the best probiotic for dogs covers selection criteria in depth, and probiotics for dogs after antibiotics is the most relevant read if your dog has just finished a course from your practice.
When to ring your practice instead
A supplement is not a substitute for a clinical assessment. Contact your RCVS-registered veterinary surgeon promptly if your dog has:
- Blood in the faeces, black tarry stools, or repeated vomiting
- Diarrhoea lasting more than 48 hours, or any diarrhoea in a puppy, a senior dog, or a small breed at risk of dehydration
- Lethargy, collapse, a painful or distended abdomen, or a suspected foreign body
- Weight loss, poor coat, or loose stools persisting for weeks — this needs investigation, not a supplement
- Any immunosuppressive treatment or serious underlying illness — live micro-organisms warrant a specific conversation with your vet first
Tell your practice about any supplement your dog is on. It is relevant context, particularly if bloods are being run — the triglyceride finding above is a small but real example of why. Persistent signs may reflect dysbiosis in dogs or a condition needing diagnosis. You can browse the full range at Pure Majesty Pets.
Frequently asked questions
Is a dog probiotic sold in the UK classed as a veterinary medicine?
No. Canine probiotics on the British market are sold as complementary feeds or feed additives, overseen under feed law rather than by the VMD. Only a product with a VMD marketing authorisation may make a medicinal claim, and no dog probiotic currently holds one.
What does "complementary feed" mean on a British dog probiotic label?
It means the product is intended to be given alongside a complete diet rather than as a diet on its own, and that its claims must stay nutritional — wording such as "may support normal digestion". A label using treatment language would be stepping outside what that category permits.
Can giving a probiotic reduce my dog's need for antibiotics?
Research does not prove that. What can be said is that UK stewardship guidance such as BSAVA PROTECT ME already discourages routine antibiotics for mild, self-limiting diarrhoea, and supportive management is often the recommended first step. One canine trial found dogs on metronidazole plus SF68 had a higher percentage of days with normal stools (P = .0496), though the day-7 difference was not significant. Any decision about antibiotics belongs to your veterinary surgeon.
Should I tell my vet practice my dog is taking a probiotic?
Yes. It is useful clinical context, especially before blood work or if your dog is on immunosuppressive medication or has a history of pancreatitis or raised blood lipids. A blinded study in healthy dogs recorded increased triglycerides by day 28, with one dog developing hypertriglyceridaemia.
How can I tell whether a UK-sold probiotic actually contains what it says?
Look for the strain named to its deposit number and for batch-level certificate of analysis. Historic testing of commercial pet products claiming probiotic content found none contained every organism listed, and roughly a quarter showed no relevant growth — which is why third-party batch verification, rather than the front-of-pack claim, is the thing to check.
Scientific References
- Bybee SN, Scorza AV, Lappin MR. J Vet Intern Med 2011;25(4):856-60. PMID 21689152
- Fenimore A, Martin L, Lappin MR. Top Companion Anim Med 2017;32(3):100-103. PMID 29291770
- Simpson KW et al. J Vet Intern Med 2009;23(3):476-81. PMID 19298607
- Benyacoub J et al. J Nutr 2003;133(4):1158-62. PMID 12672936
- Nybroe S et al. Animals (Basel) 2022;13(1):144. PMID 36611752
- Lucena R et al. J Vet Intern Med 2019;33(6):2628-2634. PMID 31578761
- Zhang R et al. Vet Sci 2025;12(5):412. PMID 40431505
- Yuan TY et al. J Vet Med Sci 2023;85(3):371-378. PMID 36724969
- Torres C et al. Microbiol Spectr 2018;6(4). PMID 30051804
- Weese JS, Arroyo L. Can Vet J 2003;44(3):212-6. PMID 12677689
- Suchodolski JS. Vet J 2016;215:30-7. PMID 27160005
Veterinary disclaimer: this article is for general information for dog owners in the UK and elsewhere and is not veterinary advice. Products discussed are complementary feeds, not veterinary medicines authorised by the VMD, and are not intended to diagnose, treat, cure or prevent any disease. Always consult your own RCVS-registered veterinary surgeon about your dog's health, particularly before starting a supplement in a dog that is unwell, immunosuppressed or receiving medication.